Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tonsillectomy for recurrent tonsillitis: the NATTINA trial.
Huang GJ, Yang XS, Tang N, Lu BQ. Huang GJ, et al. Among authors: lu bq. Lancet. 2024 Apr 27;403(10437):1633-1634. doi: 10.1016/S0140-6736(24)00190-9. Lancet. 2024. PMID: 38677857 No abstract available.
Wnt3a-Loaded Hydroxyapatite Nanowire@Mesoporous Silica Core-Shell Nanocomposite Promotes the Regeneration of Dentin-Pulp Complex via Angiogenesis, Oxidative Stress Resistance, and Odontogenic Induction of Stem Cells.
Luo N, Deng YW, Wen J, Xu XC, Jiang RX, Zhan JY, Zhang Y, Lu BQ, Chen F, Chen X. Luo N, et al. Among authors: lu bq. Adv Healthc Mater. 2023 Sep;12(22):e2300229. doi: 10.1002/adhm.202300229. Epub 2023 May 11. Adv Healthc Mater. 2023. PMID: 37186211
[Guideline for clinical comprehensive evaluation of Chinese patent medicine (2022 version)].
Yuan WA, Zhang JH, Liu JP, Yang ZQ, Cao JL, Liao X, Xi XY, Han M, Li WY, Qiu ZW, Feng SY, Guo YY, Cao LJ, Liao XH, Ai YL, Huang J, Jia LL, Su XF, Wu X, Dai ZQ, Guo JH, Lu BQ, Zhang XX, Tang JY. Yuan WA, et al. Among authors: lu bq. Zhongguo Zhong Yao Za Zhi. 2023 Jan;48(1):256-264. doi: 10.19540/j.cnki.cjcmm.20220922.501. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 36725278 Chinese.
Efficacy and Safety of Modified Yupingfeng Nasal Spray in Controlling the Recurrence of Persistent and Moderate-Severe Allergic Rhinitis: Study Protocol for a Multicenter, Open-Label, Randomized, and Parallel-Arm Trial.
Liu T, Lu BQ, Wang DD, Liao C, Chiang HJ, Zhang R, Xi Y, Tian L. Liu T, et al. Among authors: lu bq. Evid Based Complement Alternat Med. 2022 Aug 10;2022:4666332. doi: 10.1155/2022/4666332. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35990824 Free PMC article.
59 results